Overview
Breaking Barriers To Better Cancer Treatment.
Incendia Therapeutics is a precision oncology biotech company redefining the cancer treatment landscape by developing a new class of drugs that overcome immune exclusion by reprogramming the tumor microenvironment (TME). Tumor immune exclusion has been linked to unfavorable clinical outcome and inadequate response to standard-of-care therapies. Leveraging our platform to deconstruct the underpinnings of the TME, we are building a pipeline of novel therapeutics.